dimpy
2023-03-10


Pharmaceutical Biotechnology & Clinical Research Jobs $ImmunityBio, Inc.(IBRX)$$Spdr S&P Biotech Etf(XBI)$ $S&P Biotech Bull 3X Shares(LABU)$ So a company thats got PDUFA on or before May 23 Is hiring but shorts keep pounding the SP two months out. The price was 6.80 in Dec and now 1.50 and little has changed except a 14 mil share direct offering at 3.50 to several institutions. 🤷🏼‍♂️. This is going to run so hard soon!!! Billionaire owner Patrick Soon Shiong already got abraxane approved and sold the company to Celgene. Approval almost certain for the Bladder cancer drug Anktiva. Do your DD. Never invest more than you can afford to lose!So short term charts are screaming a bounce coming next. 1H, 2H, 4H are all in solid oversold territory. Daily has some room to go. Weekly is a very different story. Take a look below and judge for yourself what comes next:

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
22